Charcot-Marie-Tooth neuropathy type 1E (CMT1E) is a very rare inherited nerve disease. It affects the peripheral nerves, which are the long nerves that carry signals between the brain, spinal cord, muscles, and skin. In CMT1E, these nerves slowly stop working well, so muscles become weak and thin, and feeling in the feet and hands is reduced.Genetic Diseases Center+1
Charcot-Marie-Tooth neuropathy type 1E (CMT1E) is a rare inherited nerve disease caused by harmful changes in the PMP22 gene. This gene problem damages the myelin covering of peripheral nerves. When the myelin is weak, signals to and from the muscles and skin travel slowly, so people develop weakness of the feet and hands, foot deformity, balance trouble, and sometimes pain or numbness. There is no cure yet. Treatment focuses on keeping muscles strong, protecting joints, reducing pain, and preventing complications with a mix of therapies, devices, and medicines. CMT Research Foundation+2PMC+2
CMT1E is a demyelinating neuropathy. This means the myelin sheath, which is the fatty “insulation” around nerves, becomes damaged or does not form correctly. When myelin is unhealthy, nerves cannot send signals fast or clearly. This causes slow nerve conduction on tests and leads to problems with walking, balance, hand use, and sometimes hearing.PMC+1
CMT1E is caused by harmful changes (mutations) in a gene called PMP22. This gene gives the instructions for a protein called peripheral myelin protein 22, which is very important for building and keeping myelin healthy. In CMT1E, the faulty PMP22 protein harms the myelin and sometimes the nerve itself. The disease is usually autosomal dominant, which means one changed copy of the gene is enough to cause the condition.CMT Research Foundation+2National Organization for Rare Disorders+2
Other names
CMT1E has many other names in medical books and databases. These names describe the same or very closely related conditions:
Charcot-Marie-Tooth disease type 1E; Charcot-Marie-Tooth disease, demyelinating, type 1E; Charcot-Marie-Tooth neuropathy type 1E; Charcot-Marie-Tooth disease and deafness; autosomal dominant Charcot-Marie-Tooth neuropathy and deafness; Charcot-Marie-Tooth disease-hearing loss syndrome; hereditary motor and sensory neuropathy type I.Genetic Diseases Center+2NCBI+2
These different names tell us that the disease is inherited, affects both movement and feeling (motor and sensory), damages myelin, and is often linked with hearing loss as well as limb weakness and numbness.MalaCards+1
Types
Even though CMT1E is one named subtype, people with CMT1E can look very different from each other. Doctors sometimes think about clinical patterns or “types” based on severity and age when symptoms start, all caused by different PMP22 mutations.PMC+1
One pattern is mild or late-onset CMT1E. In this pattern, symptoms start in teenage years or adult life. People may have mild foot weakness, high-arched feet, and slight numbness, but can still walk and work almost normally. Nerve tests show demyelination, but disability progresses slowly.PMC+1
Another pattern is classic childhood-onset CMT1E. Here, symptoms usually begin between about 5 and 15 years. Children develop clumsy walking, frequent falls, high arches, and weak ankles. Over time, weakness and numbness spread to the hands. Hearing loss can appear in some patients.PMC+1
A third pattern is severe early-onset or Dejerine–Sottas-like CMT1E. In this form, symptoms start in infancy or very early childhood. Babies may have delayed walking, very weak legs, and marked nerve demyelination on tests. They may develop more disability, spine curvature, and sometimes intellectual or hearing problems.PMC+2Wiley Online Library+2
Some CMT1E cases are described as CMT1E with deafness. In this pattern, patients have typical CMT features plus sensorineural hearing loss, so they may need hearing aids or cochlear implants. This is why some names for CMT1E include “disease-deafness” or “hearing loss syndrome.”MalaCards+1
Causes
All true root causes of CMT1E are genetic. Lifestyle, infections, or trauma do not create the disease, but they can sometimes make symptoms worse. Below are 20 genetic and biological mechanisms that “cause” or strongly shape CMT1E.
PMP22 point mutation
The main cause of CMT1E is a point mutation in the PMP22 gene. A point mutation means a single DNA letter is changed. This small change can alter the PMP22 protein so that it no longer supports normal myelin, leading to demyelinating neuropathy and hearing loss in some patients.CMT Research Foundation+2National Organization for Rare Disorders+2PMP22 missense variants
Many CMT1E families carry missense mutations, where one amino acid in the PMP22 protein is replaced by another. These missense changes can disturb protein folding, cause abnormal trafficking inside Schwann cells, and damage myelin, giving a “toxic gain-of-function” effect.PMC+1PMP22 small insertions
Some CMT1E cases are due to small insertion mutations in PMP22. Extra DNA bases are added, which shifts the reading frame and makes a faulty protein. This abnormal protein can stress myelin-forming cells and disrupt nerve insulation.Lippincott Journals+1PMP22 small deletions
The opposite problem is a small deletion, where a few DNA bases are missing. This also can shift the reading frame or remove important amino acids. The result is a shortened or unstable PMP22 protein that cannot support healthy myelin.PMC+1PMP22 truncating mutations
Some mutations create an early “stop” signal in the gene, producing a truncated PMP22 protein. This shortened protein may be quickly destroyed or may harm the cell if it builds up, leading to severe early-onset neuropathy.PMC+1Disrupted PMP22 folding and ER stress
Misfolded PMP22 proteins can get stuck inside the endoplasmic reticulum (ER) of Schwann cells. This causes ER stress, activates stress pathways, and may lead to Schwann-cell injury and demyelination, which is a key mechanism in severe CMT1E.PMC+1Abnormal myelin compaction
PMP22 is crucial for tight packing (compaction) of myelin layers. Mutant PMP22 can make myelin loose or split. Poor compaction means nerve signals leak and slow down, which is seen as low conduction velocity on nerve conduction studies in CMT1E.PMC+1Schwann-cell dysfunction
Because PMP22 is mainly produced in Schwann cells, mutations directly cause Schwann-cell dysfunction. Sick Schwann cells cannot properly support or repair myelin, and over time the underlying axon (nerve fiber) may also be damaged.MDPI+1Axonal degeneration secondary to demyelination
Long-lasting demyelination from PMP22 mutations can lead to axonal loss. Once axons degenerate, weakness and sensory loss become more permanent. This secondary axon damage explains progressive disability in some CMT1E patients.PMC+1Autosomal dominant inheritance from an affected parent
Most patients inherit one mutated PMP22 gene from an affected parent. This is called autosomal dominant inheritance. Each child of an affected person has a 50% chance to inherit the mutation and develop CMT1E.NCBI+1De novo PMP22 mutations
Some people with CMT1E are the first case in their family. This happens when a new (de novo) PMP22 mutation appears in the egg or sperm or early embryo. Even though their parents are healthy, the person can still pass the mutation to their own children.Springer Link+1Mutation-specific severity
Different PMP22 mutations lead to different disease severities. Some variants cause mild late-onset disease; others cause early, very severe neuropathy with hearing loss and developmental problems. So the exact mutation is a cause of how serious CMT1E will be.PMC+2ResearchGate+2Dominant-negative effects on myelin
Some mutant PMP22 proteins may interfere with the normal protein made from the healthy gene copy. This dominant-negative effect worsens myelin damage, even though one copy of the gene is normal, and can cause severe forms of CMT1E.PMC+1Toxic gain-of-function mechanisms
For several mutations, CMT1E seems to be caused by toxic gain-of-function, where the mutant protein actively harms the cell, rather than simply being missing. This toxic effect may include protein clumping, stress responses, and disturbed cell membranes in Schwann cells.PMC+1Abnormal PMP22 dosage or trafficking
Some PMP22 mutations can change how much protein is present in the myelin or where it is located inside the cell. Wrong dosage or trafficking of PMP22 can upset the delicate balance of myelin proteins and destabilize the sheath.PMC+1Interaction with other myelin proteins
PMP22 works together with other myelin proteins, such as MPZ. Mutant PMP22 may disturb these protein–protein interactions, making myelin more fragile and leading to demyelination in CMT1E.PMC+1Length-dependent vulnerability of long nerves
Long nerves to the feet and hands are more vulnerable to any myelin problem. So PMP22 mutations particularly damage long peripheral nerves, which is why symptoms usually start in the feet and later in the hands.ScienceDirect+1Possible cochlear nerve involvement
Because PMP22 is expressed in peripheral nerves, some mutations can also affect the auditory (hearing) nerve or related pathways. This may explain why some CMT1E patients have sensorineural hearing loss.MalaCards+1Modifier genes and background genetics
Other genes may modify how severe the PMP22 mutation’s effect is. Different genetic backgrounds can partly explain why people with the same PMP22 mutation have different levels of weakness and hearing problems.PMC+1Time-dependent accumulation of nerve damage
CMT1E is a chronic condition. Over many years, repeated demyelination and axonal injury accumulate. This time-dependent damage is a cause of slow progression, increasing disability, and sometimes the later appearance of hearing or balance problems.PMC+1
Symptoms
Progressive distal muscle weakness
The most common symptom is slowly increasing weakness in the feet and lower legs. People may notice trouble running, climbing stairs, or standing on tiptoe. Over time, the weakness can spread to the hands, making fine tasks harder.PMC+1Muscle wasting in feet and legs
As nerves stop working well, the muscles they supply become thinner. The lower legs may look like an “inverted champagne bottle,” with small calves. This muscle wasting makes walking and balance more difficult.actionability.clinicalgenome.org+1High-arched feet (pes cavus)
Many people with CMT1E develop high-arched feet and sometimes hammer toes. These changes come from long-term muscle imbalance around the ankles and toes. The deformity can cause pain, calluses, and trouble finding comfortable shoes.PMC+1Foot drop and tripping
Weakness of the muscles that lift the front of the foot leads to foot drop. The toes drag on the ground, so the person may trip or fall often. They may lift their knees higher when walking to avoid catching the toes.PMC+1Hand weakness and poor fine motor skills
Later in the disease, the small muscles of the hands can weaken. People may have trouble buttoning clothes, using keys, writing, or using a phone. This fine motor difficulty can affect school, work, and daily activities.actionability.clinicalgenome.org+1Numbness and reduced sensation
CMT1E affects sensory fibers as well. People often feel numbness, tingling, or reduced feeling in their feet and hands. They may not notice small injuries or changes in temperature, which can increase risk of skin problems.Genetic Diseases Center+1Loss of vibration and position sense
Many patients lose their ability to feel vibration (for example, from a tuning fork) and to sense where their feet are in space (proprioception). This makes walking in the dark or on uneven ground very challenging.PMC+1Balance problems and unsteady gait
Weak muscles, numbness, and loss of position sense together cause poor balance. The gait can become wide-based or wobbly, and people may use rails or walking aids, especially on stairs and rough surfaces.PMC+1Absent or reduced reflexes
On examination, doctors often find reduced or absent tendon reflexes, especially at the ankles and knees. This is a typical sign of peripheral neuropathy and is common in CMT1E.Charcot-Marie-Tooth Association+1Neuropathic pain and cramps
Some people have burning, shooting, or electric-like pain in their feet and legs, called neuropathic pain. Muscle cramps and fatigue are also frequently reported and can reduce sleep quality and daily comfort.actionability.clinicalgenome.org+1Hearing loss
A key feature of many CMT1E cases is sensorineural hearing loss. This may start in childhood or later. People may have trouble following conversations, especially in noisy places, and often benefit from hearing evaluation and hearing aids.MalaCards+1Slow motor nerve conduction on tests
Although this is a test finding, its effect in real life is that muscles respond slowly and weakly because motor nerve conduction velocity is greatly reduced. This matches the demyelinating nature of CMT1E.PMC+1Orthopedic complications (scoliosis, hip problems)
Some patients develop spine curvature (scoliosis) or hip deformities. These problems come from long-standing muscle imbalance and weakness and can add pain or further impact mobility.actionability.clinicalgenome.org+1Fatigue and reduced stamina
Chronic muscle weakness, extra effort needed to walk, and possible sleep disruption from pain lead to fatigue. People may feel tired after short walks or daily tasks, which affects school, work, and social life.actionability.clinicalgenome.org+1Psychological and social impact
Living with a long-term progressive condition and visible deformities can cause low mood, anxiety, or social withdrawal. Fear of falls, hearing difficulties, and needing mobility aids can also affect confidence and independence.ScienceDirect+1
Diagnostic tests
Diagnosis of CMT1E is based on the clinical picture, nerve tests, and confirmation of a PMP22 mutation. Below are 20 important tests grouped by category.
Physical exam tests
General neurological examination
The doctor checks muscle bulk, strength, sensation, reflexes, and coordination from head to toe. In CMT1E, they usually see thin distal muscles, reduced strength in feet and hands, loss of certain sensations, and weak or absent reflexes. This exam guides further testing.ScienceDirect+1Gait and posture observation
The clinician watches how the person walks, stands, and turns. They look for foot drop, high steps, ankle instability, and balance problems. In CMT1E, gait may be steppage-like with frequent tripping and difficulty walking on heels or toes.PMC+1Foot and spine inspection
The doctor closely inspects the feet for high arches, hammer toes, calluses, and deformities, and looks at the spine for scoliosis. These findings support the diagnosis of a long-standing hereditary neuropathy like CMT1E.PMC+1Cranial nerve and hearing-related exam
Because CMT1E can be associated with hearing loss, doctors test cranial nerves, including simple bedside hearing checks (whisper test, tuning fork). If hearing seems reduced, they refer for audiology. This helps identify the “disease-hearing loss syndrome” pattern.MalaCards+1
Manual functional tests
Heel-toe walking test
The person is asked to walk on heels and then on toes. Weak ankle dorsiflexors cause difficulty walking on heels, while weak calf muscles affect toe walking. This simple manual gait test shows distal leg weakness typical of CMT1E.PMC+1Single-leg stance and Romberg test
In single-leg stance and Romberg, the patient stands with feet together, sometimes with eyes closed. Swaying or falling shows poor position sense and balance. These manual tests are sensitive for sensory ataxia from peripheral neuropathy.Wiley Online Library+1Hand grip and pinch strength testing
The clinician asks the patient to squeeze their fingers or a device and perform pinch tasks. Weakness of intrinsic hand muscles is common in later CMT1E. These manual tests show how much hand function is affected.actionability.clinicalgenome.org+1Fine motor task testing (buttons, writing)
The patient is asked to button a shirt, pick up small objects, or write. Slowness, dropping objects, or poor coordination indicate fine motor impairment from hand neuropathy. This helps assess daily functional impact.PMC+1
Laboratory and pathological tests
Genetic testing for PMP22 point mutations
The key confirmatory test is DNA testing that sequences the PMP22 gene to look for point mutations, small insertions, deletions, or truncating variants. Finding a known pathogenic PMP22 mutation together with the clinical features confirms CMT1E.Springer Link+2ResearchGate+2Expanded CMT gene panel testing
Sometimes doctors order a multi-gene panel for Charcot-Marie-Tooth disease. This panel checks PMP22 and many other CMT-related genes. It is useful if the clinical picture is unclear or if more than one gene could be involved.ScienceDirect+1Basic blood tests to exclude other neuropathies
Routine lab tests (blood sugar, vitamin B12, thyroid function, kidney and liver tests, immune markers) are done to rule out acquired neuropathies such as diabetic neuropathy, vitamin deficiency, or autoimmune disease. Normal or non-specific results support a genetic cause like CMT1E.ScienceDirect+1Nerve biopsy (rarely needed)
In uncertain cases, a nerve biopsy (usually sural nerve) may be performed. In demyelinating CMT, biopsy can show onion-bulb formations and myelin abnormalities. Today, biopsy is less common because genetic testing is more precise and less invasive.Springer Link+1Audiology (hearing tests)
Formal hearing tests, such as pure-tone audiometry, measure how well the person hears sounds at different pitches and volumes. In CMT1E with deafness, these tests show sensorineural hearing loss, supporting the diagnosis of a neuropathy-hearing loss syndrome.MalaCards+1Family genetic studies
Testing parents, siblings, or children for the identified PMP22 mutation helps confirm autosomal dominant inheritance and can guide genetic counseling. Finding the same mutation in relatives with similar features strongly supports CMT1E.Springer Link+1
Electrodiagnostic tests
Nerve conduction studies (NCS)
NCS measure how fast and how strongly electrical signals travel along nerves. In CMT1E, motor and sensory conduction velocities are markedly slowed, indicating a demyelinating neuropathy. These results point toward a CMT1 pattern and help distinguish it from axonal forms.PMC+1Electromyography (EMG)
EMG uses a small needle electrode to record electrical activity from muscles. In CMT1E, EMG often shows signs of chronic denervation and reinnervation, such as large motor units. EMG supports the presence of a long-standing neuropathy and helps rule out primary muscle disease.PMC+1Evoked potentials (in selected cases)
In some patients, especially with suspected central or auditory involvement, evoked potential tests (such as brainstem auditory evoked responses) may be done. Abnormal results can show problems along sensory or auditory pathways, helping to link neuropathy and hearing loss.MalaCards+1
Imaging tests
Peripheral nerve ultrasound
High-resolution nerve ultrasound can show enlarged and irregular nerves in inherited neuropathies. In demyelinating CMT, including PMP22-related types, ultrasound may reveal thickened nerve trunks, which support the diagnosis of a hereditary neuropathy.neuromuscular.wustl.edu+1MRI of nerve roots and plexus
Magnetic resonance imaging (MRI) of the spine and nerve roots can show enlargement and abnormal signal in nerves in some CMT1 patients. This imaging helps exclude other causes (like tumors or inflammatory neuropathies) and supports chronic demyelinating disease.neuromuscular.wustl.edu+1X-rays of feet and spine
Simple X-rays can document high arches, toe deformities, and spinal curvature. While they do not show nerve damage, they help plan orthopedic treatment, braces, or surgery and show long-term effects of the neuropathy.actionability.clinicalgenome.org+1
Non-pharmacological treatments
1. Physical therapy (PT)
A long-term physical therapy plan is one of the most important parts of CMT1E care. A physiotherapist teaches safe, low-impact exercises to make weak muscles stronger and to keep joints flexible. Regular PT can slow contractures (joint stiffness), improve balance, and help you walk more safely. Starting early and continuing for life can delay disability and support better posture and energy in daily life. PMC+1
2. Occupational therapy (OT)
Occupational therapists help you manage daily tasks like dressing, cooking, writing, and using a computer. They suggest hand exercises and simple tools such as built-up pens, zipper pulls, and adapted cutlery. This therapy protects joints from strain and teaches ways to work with less pain and fatigue. The main goal is to keep you independent at home, school, and work for as long as possible. Mayo Clinic
3. Ankle-foot orthoses (AFOs)
AFOs are custom braces that support weak ankles and lift the toes so you do not trip. In CMT1E, foot-drop and high-arched “cavus” feet are common, so braces can make walking smoother and safer. They also help control ankle sprains and reduce uneven pressure on the feet, which protects the skin and joints over many years. CMT Research Foundation+1
4. Custom shoes and insoles
Special shoes and in-shoe inserts spread body weight more evenly across the foot. They soften pressure under bony areas and help correct mild deformity. For someone with CMT1E, good footwear reduces pain, prevents calluses and ulcers, and improves stability while walking on uneven ground. A podiatrist or orthotist usually designs and adjusts these devices. PMC+1
5. Walking aids (cane, crutches, walker)
When weakness and balance problems increase, a cane, crutch, or walker can make walking safer. These aids widen your base of support and reduce the risk of falls. Over time, using a walking aid may also protect your joints and spine, because your body does not need to compensate with abnormal postures to stay upright. PMC+1
6. Balance and gait training
Specific exercises such as standing on one leg (with support), walking in a straight line, or practicing turns can train your brain and inner ear to work better with weak muscles. Therapists also teach safe recovery strategies after a stumble. This type of training lowers fall risk and builds confidence during daily activities. PMC+1
7. Stretching and contracture prevention
Regular gentle stretching of calves, hamstrings, hips, and hands helps prevent tight tendons and frozen joints. In CMT1E, ankles and toes tend to curl, and Achilles tendons can shorten. Daily stretching, sometimes with night splints, keeps joints in a better position and may delay the need for surgery. PMC
8. Hand and fine-motor training
Weak hand muscles can make writing and buttoning difficult. OT-guided hand exercises, soft putty, and grip tools can strengthen small muscles and improve dexterity. Practicing simple tasks in a structured way trains the nervous system to use remaining strength more efficiently and supports school and computer work. PMC
9. Low-impact aerobic exercise
Swimming, cycling, or using an elliptical trainer offer gentle cardio exercise without heavy stress on joints or weak muscles. Regular aerobic activity improves stamina, heart health, and mood. In people with peripheral neuropathy, carefully supervised exercise can also help glucose control and weight management, which indirectly protects nerves and muscles. PMC+1
10. Pain psychology and cognitive-behavioural therapy (CBT)
Chronic neuropathic pain can change how the brain processes signals and how you feel emotionally. CBT and other pain-focused psychological therapies teach coping skills, relaxation methods, and pacing techniques. These approaches can lower the emotional burden of pain and often improve sleep and quality of life, even if nerve damage itself does not change. Charcot-Marie-Tooth Association
11. Vocational and school rehabilitation
Career counsellors and vocational therapists help match your education and job to your physical limits. They may recommend ergonomic desks, speech-to-text software, flexible hours, or remote work. Early planning reduces stress, prevents overuse injuries, and keeps you engaged in education and employment. PMC
12. Home safety modifications
Simple changes at home—grab bars in the bathroom, non-slip mats, good lighting, removing loose rugs—greatly reduce fall risk. For CMT1E, where balance and foot control are affected, these changes are as important as medicines. An occupational therapist can perform a home safety assessment and suggest low-cost improvements. Mayo Clinic
13. Fall-prevention programs
Structured fall-prevention plans combine exercise, home changes, and education. They teach how to stand up safely, how to turn slowly, and how to choose safe footwear. Reducing falls means fewer fractures, head injuries, and hospital stays—key goals in long-term CMT management. PMC+1
14. Fatigue management and energy conservation
CMT1E can make everyday tasks feel exhausting because muscles work harder to compensate for weakness. Therapists teach “energy budgeting”: planning tasks, taking scheduled rests, sitting rather than standing when possible, and using tools that save effort. These strategies reduce fatigue and help you participate more in school, work, and social activities. PMC
15. Respiratory and sleep assessment (if needed)
Some people with CMT develop breathing or sleep problems, especially if spine or chest muscles are involved. Sleep studies, breathing tests, and sometimes non-invasive ventilation can improve sleep quality and daytime energy. Treating sleep apnea or hypoventilation may also protect the heart and brain over the long term. PMC+1
16. Orthopaedic monitoring of feet and spine
Regular review by an orthopaedic specialist helps track foot deformity, scoliosis, and joint wear. Early detection allows timely braces or surgery. This long-term monitoring aims to keep you walking as independently as possible and to prevent severe fixed deformities that are harder to treat. PMC+1
17. Genetic counselling
CMT1E is inherited. Genetic counsellors explain how the PMP22 mutation is passed in a family, what it means for future children, and what testing options exist for relatives. This counselling supports informed choices about family planning and helps reduce fear and guilt in affected families. Wikipedia+1
18. Psychological counselling and peer support
Living with a chronic, visible disability can cause anxiety, sadness, or social isolation. Talking with a psychologist or joining a CMT support group allows you to share experiences, learn coping skills, and feel less alone. Better mental health often improves pain perception and motivation to follow therapy plans. PMC+1
19. Education and self-management training
Learning about CMT1E—how it progresses, what helps, and what harms your nerves—makes you an active partner in care. Education covers safe sports, shoe choice, skin care, and warning signs that need medical review. Informed patients are more likely to follow treatment and avoid risky behaviours. CMT Research Foundation+1
20. Community and disability resources
Access to disability benefits, mobility services, and inclusive education or work policies can reduce financial and social stress. Social workers help you navigate these systems. This support does not directly repair nerves, but it reduces the overall burden of disease and improves quality of life. PMC
Drug treatments for CMT1E-related problems
Important: No drug is currently approved to cure CMT or specifically reverse CMT1E. Most medicines below are used to treat neuropathic pain, muscle symptoms, mood, or sleep and are based on evidence from other neuropathies. PMC+2Charcot-Marie-Tooth Association+2
For all medicines, your doctor will choose the dose based on age, kidney function, and other conditions. Example dose ranges below come from FDA-approved labels for similar conditions, not personal advice.
1. Gabapentin (Neurontin, others)
Gabapentin is an anti-seizure drug widely used for neuropathic pain. It calms overactive nerve firing in damaged sensory fibres. FDA labels for post-herpetic neuralgia show typical adult total doses between about 1,800–3,600 mg per day divided into three doses. Common side effects are sleepiness, dizziness, and swelling of legs. In CMT1E, doctors may try gabapentin to reduce burning or shooting pain, always slowly adjusting the dose. Charcot-Marie-Tooth Association+3FDA Access Data+3FDA Access Data+3
2. Pregabalin (Lyrica, Lyrica CR)
Pregabalin is related to gabapentin and also blocks certain calcium channels in nerve cells, which reduces release of pain-related chemicals. For diabetic neuropathy and other FDA-approved neuropathic conditions, labels suggest total daily doses around 150–600 mg, in two or three divided doses. Side effects include dizziness, drowsiness, weight gain, and ankle swelling. In CMT1E, it may be used when pain is severe or when gabapentin is not enough. Charcot-Marie-Tooth Association+4FDA Access Data+4FDA Access Data+4
3. Duloxetine
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is also approved for diabetic neuropathic pain. It increases the level of certain brain chemicals that dampen pain signals coming from the spinal cord. Common adult doses for neuropathic pain are about 60–120 mg once daily. Side effects may include nausea, dry mouth, and sleep changes. In CMT1E, duloxetine is useful when pain and low mood exist together. Charcot-Marie-Tooth Association+1
4. Venlafaxine
Venlafaxine is another SNRI with evidence for neuropathic pain relief. It works in a similar way to duloxetine by boosting pain-modulating pathways in the brainstem. Typical doses for depression range widely, and neuropathic pain often responds at moderate doses. Side effects can include increased blood pressure, sweating, and stomach upset. Doctors may choose venlafaxine when duloxetine is not tolerated. Charcot-Marie-Tooth Association+1
5. Amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) used in low doses for nerve pain and sleep. It blocks reuptake of serotonin and norepinephrine and also reduces sensitivity of pain pathways. Bedtime doses for pain are usually much lower than antidepressant doses. Dry mouth, constipation, and drowsiness are common, and it can affect heart rhythm, so ECG monitoring may be needed. Charcot-Marie-Tooth Association+1
6. Nortriptyline
Nortriptyline is a newer TCA with similar benefits to amitriptyline but often fewer sedating and anticholinergic side effects. It is used at night to improve sleep and neuropathic pain. Doctors usually start at very low doses and increase slowly to avoid dizziness and heart rhythm problems. It can be a good option for adults who cannot tolerate amitriptyline. Charcot-Marie-Tooth Association+1
7. Carbamazepine
Carbamazepine is an anti-seizure drug widely used for trigeminal neuralgia and sometimes other nerve pains. It stabilizes sodium channels in nerve membranes, making them less likely to fire abnormally. It can cause dizziness, low sodium levels, and rare but serious blood or liver problems, so regular blood tests are important. It is usually considered when first-line neuropathic pain medicines fail. Charcot-Marie-Tooth Association+1
8. Oxcarbazepine
Oxcarbazepine is related to carbamazepine but often has a slightly better side-effect profile. It also blocks overactive sodium channels. It is sometimes used off-label for neuropathic pain. Side effects include dizziness, tiredness, and low sodium. Doctors may choose it for patients who did not tolerate carbamazepine but still need this class of medicine. Charcot-Marie-Tooth Association+1
9. Lamotrigine
Lamotrigine is an anti-seizure medication that modulates sodium channels and glutamate release. Some studies show benefit in certain neuropathic pain conditions, although the evidence is weaker than for gabapentinoids, SNRIs, or TCAs. It must be started very slowly to reduce the risk of serious skin rash (Stevens–Johnson syndrome). In CMT1E it is a second- or third-line option. Charcot-Marie-Tooth Association+1
10. Topical lidocaine 5% patch
Lidocaine patches deliver a local anaesthetic through the skin directly over the painful area. They block sodium channels in nerve endings, reducing pain without strong whole-body side effects. Patches are usually applied for up to 12 hours per day. They are especially useful for focal pain on the feet in CMT1E. Charcot-Marie-Tooth Association+1
11. High-strength capsaicin patch (8%)
Capsaicin, derived from chilli peppers, temporarily depletes pain-signalling chemicals (substance P) from nerve endings. A high-strength patch is applied by a trained professional and can give relief for weeks or months in localized neuropathic pain. It can cause intense burning during and shortly after application, so careful monitoring is needed. Charcot-Marie-Tooth Association+1
12. Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs such as ibuprofen or naproxen are not very effective for pure nerve pain, but they help with muscle and joint pain from abnormal walking patterns, sprains, or surgery. They reduce inflammatory chemicals (prostaglandins) in tissues. Long-term use can irritate the stomach or affect kidneys and should be monitored. PMC+1
13. Acetaminophen (paracetamol)
Acetaminophen helps mild to moderate musculoskeletal pain and can be combined with other medicines. It works mainly in the brain to change pain perception. It does not reduce inflammation, but it is usually easier on the stomach than NSAIDs when used at recommended total daily doses. Overdose can damage the liver, so maximum daily amounts must never be exceeded. Charcot-Marie-Tooth Association+1
14. Tramadol (short-term use)
Tramadol is a weak opioid that also affects serotonin and norepinephrine pathways. It can help short-term severe neuropathic pain but carries risks of dependence, nausea, dizziness, and rare seizures. For CMT1E, guidelines usually reserve opioids for very resistant cases and try to limit dose and duration as much as possible. Charcot-Marie-Tooth Association+1
15. Baclofen
Baclofen is a muscle relaxant that acts on GABA receptors in the spinal cord, reducing spasticity and cramps. Some people with CMT experience painful muscle tightness, especially at night. Low doses of baclofen may ease these spasms but can cause drowsiness and weakness, so careful titration is needed. PMC+1
16. Tizanidine
Tizanidine is another muscle relaxant that reduces muscle tone via alpha-2 adrenergic receptors. It can relieve painful spasm and improve sleep, but side effects include sleepiness, dry mouth, and low blood pressure. It is usually used when other spasm treatments are not enough. PMC+1
17. Botulinum toxin injections
In selected cases with very tight muscles or specific deformities, local botulinum toxin injections can weaken overactive muscles for several months. This can reduce pain, improve limb position, or delay surgery. Injections must be done by an experienced specialist, as over-weakening a muscle may worsen function. PMC+1
18. Antidepressants for mood (e.g., SSRIs)
Living with chronic pain and disability increases the risk of depression and anxiety. Selective serotonin reuptake inhibitors (SSRIs) such as sertraline are used to improve mood and overall coping. Although they are not primary pain medicines, better mental health often makes pain easier to manage and improves participation in therapy. Charcot-Marie-Tooth Association
19. Sleep medicines (short term)
Poor sleep worsens pain, fatigue, and mood. Sometimes doctors use short-term sleep medicines or low-dose sedating antidepressants to break a cycle of severe insomnia. These are chosen carefully to avoid falls or confusion. Non-drug sleep strategies are always used alongside, such as regular bedtime and limiting screens. Charcot-Marie-Tooth Association+1
20. Investigational drug PXT3003 (for CMT1A, research only)
PXT3003 is a combination of baclofen, naltrexone, and sorbitol studied as a disease-modifying therapy for CMT1A. Clinical trials showed promising improvement in function, and research continues toward possible approval. Although not designed for CMT1E, it illustrates how future drugs may target PMP22-related disease mechanisms. Dosing is determined only inside trials. NeurologyLive+3PubMed+3ClinicalTrials.gov+3
Dietary molecular supplements
Evidence for supplements in CMT1E is limited. Most data come from diabetic or other peripheral neuropathies. Always discuss with your doctor before using any supplement.
1. Alpha-lipoic acid (ALA)
ALA is an antioxidant that helps recycle other antioxidants and may reduce oxidative stress in nerves. Meta-analyses in diabetic neuropathy suggest that doses around 600–1,800 mg/day can modestly improve pain and nerve conduction in some patients, though evidence is mixed. Side effects include stomach upset and rarely low blood sugar. Exploration Publishing+3MDPI+3PubMed+3
2. Acetyl-L-carnitine (ALC)
ALC helps transport fatty acids into mitochondria, supporting energy production in nerve cells. Trials in painful peripheral neuropathy report moderate pain reduction and possible nerve regeneration at doses often around 1–3 g/day, divided. It is usually well tolerated, with mild nausea or restlessness in some people. ClinicalTrials.gov+3PMC+3PLOS+3
3. Vitamin B12 (methylcobalamin or hydroxocobalamin)
Vitamin B12 is essential for myelin formation and DNA synthesis in nerve cells. Deficiency can cause neuropathy by itself, and treatment can reverse symptoms in many cases. Replacement can be given by injection or high-dose oral tablets; protocols vary. Side effects are rare. In CMT1E, doctors often check and correct B12 to remove any extra damage. nhs.uk+4Cleveland Clinic+4PubMed+4
4. Folate (vitamin B9)
Folate works together with B12 in methylation reactions important for nerve and blood cells. Low folate levels can worsen neuropathy. Supplementation in deficiency states may help nerve symptoms, usually via standard multivitamins or prescription folate. Very high doses should be avoided without supervision, especially if B12 status is unclear. AAFP+1
5. Omega-3 fatty acids (EPA/DHA)
Omega-3 fats from fish oil or algae have anti-inflammatory and neuroprotective effects in animal models of peripheral nerve injury and may support nerve membrane health. Human trials in neuropathy show uncertain benefit, but omega-3s clearly support general cardiovascular and brain health when taken in safe doses. High doses can increase bleeding and may affect heart rhythm, so medical guidance is important. Verywell Health+5PMC+5Queen Mary University of London+5
6. Vitamin D
Vitamin D is vital for bone, muscle, and immune health. Low vitamin D levels are common in people with limited outdoor activity or chronic illness and can worsen muscle weakness and falls. Correcting deficiency with standard vitamin D supplements may improve strength and balance, especially when combined with exercise. Excessive dosing can cause high calcium levels, so blood tests are needed. nhs.uk
7. Magnesium
Magnesium is involved in nerve conduction and muscle relaxation. In some people, correcting low magnesium may reduce muscle cramps. It is often taken in moderate doses in the evening. Too much magnesium can cause diarrhoea and, rarely, heart rhythm issues in kidney disease, so dosing should follow medical advice. nhs.uk
8. Coenzyme Q10 (CoQ10)
CoQ10 is a key part of mitochondrial energy production. Small studies in neuromuscular and mitochondrial disorders suggest it may improve fatigue and muscle performance in some patients. Typical supplement doses vary widely. Evidence is not specific to CMT1E, so it is usually considered only after discussion of potential benefits, costs, and uncertain data. PMC+1
9. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant properties in experimental models. Some early research suggests it may modulate pain pathways and reduce inflammatory signalling, but high-quality neuropathy trials are limited. It is often taken with black pepper extract to improve absorption, but it can interact with blood-thinning medicines. PMC+1
10. Multivitamin with trace elements
A balanced multivitamin-mineral supplement can help cover small gaps in diet, including B-vitamins, zinc, and copper, all relevant to nerve function. It is not a cure for CMT1E but may support overall health when diet is limited. Mega-dose formulations are usually unnecessary and may be harmful, so standard doses are preferred. nhs.uk+1
Immunity-booster and regenerative / stem-cell-related drugs
At present, no immune-booster, regenerative, or stem-cell drug is approved to cure CMT1E. The options below are either general health-supporting treatments or experimental approaches under study.
1. Vitamin B12 injections
In people with low B12 levels, intramuscular cyanocobalamin or hydroxocobalamin injections can reverse deficiency neuropathy and may support myelin health. Standard regimens use frequent injections at first, then monthly maintenance. In CMT1E, this does not fix the gene problem but removes one extra cause of nerve damage. nhs.uk+3PubMed+3ScienceDirect+3
2. High-dose vitamin D in deficiency
When blood tests show severe vitamin D deficiency, doctors may prescribe short courses of high-dose vitamin D to restore normal levels, then a lower maintenance dose. Correcting deficiency can improve muscle strength and immune function and lower fall risk. This is not specific to CMT1E but supports overall resilience. nhs.uk
3. Vaccination to protect from infections
Standard vaccines (influenza, COVID-19, pneumococcal, etc.) strengthen the immune system’s memory against serious infections. For people with CMT1E, avoiding severe infections and long hospital stays is very important, because illness can worsen weakness and mobility. Vaccine schedules follow national guidelines, not special CMT rules. nhs.uk+1
4. Intravenous immunoglobulin (IVIG) – for other neuropathies
IVIG is a blood-derived product used for immune-mediated neuropathies like Guillain–Barré and CIDP. It works by modulating harmful antibodies. It is not proven to help genetic CMT1E, but is mentioned here because sometimes people with CMT are mistakenly treated for immune neuropathy. True use is limited to confirmed immune conditions, with specialist dosing in hospital. PMC+1
5. Experimental gene therapies
Recent research explores gene-silencing, gene-addition, and gene-editing approaches to correct or reduce harmful PMP22 activity in CMT. Viral vectors deliver genetic material to Schwann cells, aiming to improve myelin health. These therapies are still in clinical or pre-clinical stages; dosing and safety are studied only in tightly controlled trials, not in routine care. NeurologyLive+4PMC+4PMC+4
6. Experimental stem-cell-based approaches
Laboratory and early clinical work is examining whether mesenchymal stem cells or other cell therapies can release growth factors, support nerve repair, or modulate immune responses in neuropathies. So far, there is no approved stem-cell treatment for CMT1E, and such therapy should only be considered within ethical, regulated clinical trials, never in unproven private “stem cell clinics.” PMC+1
Surgeries
1. Foot osteotomy
In cavovarus feet (very high arches and inward-tilted heels), surgeons may cut and realign bones of the foot to create a more normal shape. This redistributes pressure, improves balance, and makes shoe fitting easier. It is usually done when braces alone cannot control pain and instability. PMC+1
2. Tendon transfer surgery
Tendon transfer moves a functioning tendon from a stronger muscle to take over the job of a weak muscle, such as lifting the foot. In CMT1E, this can reduce foot-drop and improve walking. It is often combined with osteotomy for best long-term alignment. PMC+1
3. Joint fusion (arthrodesis)
When joints in the foot or ankle become fixed in a very abnormal position and are painful, surgeons may fuse them in a better position. This removes movement but gives stability and can greatly reduce pain. Fusion is usually reserved for severe, rigid deformity. PMC+1
4. Spine surgery for scoliosis
Some people with CMT develop scoliosis (sideways curvature of the spine). If the curve is large, painful, or affects breathing, spinal fusion with rods and screws may be needed. The goal is to straighten and stabilize the spine, protect the lungs, and prevent further deformity. PMC+1
5. Nerve decompression (e.g., carpal tunnel release)
Weak muscles can change joint positions and increase pressure on certain nerves, such as the median nerve at the wrist. If there is clear evidence of entrapment neuropathy, surgical decompression can reduce numbness and pain and protect remaining nerve fibres. This does not cure CMT1E but treats a secondary problem. PMC+1
Preventions
Protect your feet every day – inspect skin, use moisturiser, trim nails carefully, and wear well-fitting shoes to prevent ulcers and infections. Mayo Clinic+1
Avoid known nerve-toxic drugs where possible (some chemotherapy agents, excessive alcohol, certain antibiotics), and always tell doctors that you have CMT1E. PMC+1
Maintain a healthy weight to reduce load on weak feet and joints and improve balance. PMC+1
Exercise regularly but safely with low-impact activities planned by your physiotherapist; avoid high-impact sports that risk ankle injury. PMC+1
Use braces and orthotics as prescribed rather than walking without them and risking falls and deformity progression. CMT Research Foundation+1
Treat infections and wounds early, especially on the feet, to avoid serious complications and hospital stays. Mayo Clinic+1
Stop smoking because it harms blood flow to nerves and delays healing. nhs.uk
Limit alcohol since heavy alcohol intake can cause neuropathy on its own and worsen balance. nhs.uk
Keep other illnesses controlled (like diabetes or thyroid disease) so they do not add extra nerve damage on top of CMT1E. nhs.uk+1
Attend regular follow-up with neurology, rehabilitation, and orthopaedic teams so changes are caught early and treated promptly. PMC+1
When to see doctors
You should see your neurologist or primary doctor regularly for routine follow-up. Seek urgent review if you notice:
Sudden or fast-worsening weakness, especially if you can no longer walk a usual distance or stand from a chair.
New severe pain, burning, or electrical shocks in feet or hands that do not improve with your usual plan.
Frequent falls, new ankle sprains, or trouble keeping your balance even with braces.
New foot wounds, ulcers, or infections, especially with redness, swelling, or fever.
Breathing trouble, new snoring, or waking unrefreshed with morning headaches (possible sleep or respiratory problems).
Changes in bladder or bowel control, or numbness around the groin, which may suggest another spinal problem. Mayo Clinic+2PMC+2
What to eat and what to avoid
What to eat
Plenty of fruits and vegetables – provide vitamins, minerals, and antioxidants that support general nerve and muscle health. nhs.uk
Lean proteins (fish, poultry, beans, lentils, tofu) – supply amino acids needed for muscle repair and immune function. nhs.uk
Whole grains (brown rice, oats, whole-wheat bread) – give steady energy and support healthy weight and blood sugar. nhs.uk
Omega-3-rich foods (salmon, sardines, walnuts, flaxseeds) – help reduce inflammation and support nervous system health. Lone Star Neurology+2Queen Mary University of London+2
Foods rich in B-vitamins (eggs, dairy, leafy greens, fortified cereals) – support nerve function and red blood cell production; helpful especially if intake was low. Cleveland Clinic+1
What to limit or avoid
Excess alcohol – can damage nerves and worsen balance and judgement. nhs.uk
Heavy sugary drinks and ultra-processed snacks – promote weight gain and may worsen metabolic problems that harm nerves. nhs.uk
Very high-dose “mega” supplements without supervision – can cause toxicity or interact with medicines, especially fat-soluble vitamins and high-dose fish oil. Cochrane+2Health+2
High-salt fast food – increases blood pressure and can worsen swelling in legs and feet. nhs.uk
Crash diets or extremely low-calorie plans – can lead to loss of muscle mass and weakness, which is especially harmful in CMT1E. nhs.uk
Frequently asked questions (FAQs)
1. Is there a cure for Charcot-Marie-Tooth neuropathy type 1E?
There is no cure yet. Current treatment focuses on rehabilitation, braces, surgery when needed, and pain control to preserve function and quality of life. Research is exploring gene therapies and disease-modifying drugs, but these are not yet available in routine care. NeurologyLive+4PMC+4PMC+4
2. Can medicines stop CMT1E from getting worse?
Today’s medicines mainly treat symptoms like pain or spasm. They do not fix the PMP22 gene or fully stop progression. However, by protecting joints, reducing falls, and treating pain and mood problems, they can slow disability and keep you active longer. PMC+2Charcot-Marie-Tooth Association+2
3. How important is physical therapy compared with drugs?
For CMT1E, physical and occupational therapy, braces, and safe exercise are just as important as medicines—and often more important. They directly support movement, balance, and independence. Medicines mainly help you feel comfortable enough to keep doing therapy and daily activities. PMC+2Mayo Clinic+2
4. Are neuropathic pain drugs safe for long-term use?
Drugs like gabapentin, pregabalin, duloxetine, and TCAs can be used long term when carefully monitored. Doctors regularly review kidney function, weight, mood, and side effects. Doses may be lowered or changed over time to the minimum that keeps pain manageable. Resed+5FDA Access Data+5FDA Access Data+5
5. Do supplements like alpha-lipoic acid or acetyl-L-carnitine really help?
Studies in diabetic and other neuropathies show modest pain relief and improved nerve function for some people using alpha-lipoic acid or acetyl-L-carnitine, but evidence in CMT is limited. They should be seen as add-ons, not replacements for core therapies, and always used under medical supervision. ScienceDirect+5MDPI+5PubMed+5
6. Can diet alone treat CMT1E?
No diet can correct the underlying gene problem, but a healthy diet supports muscles, bones, and the immune system and helps maintain a healthy weight. This makes walking and exercise easier and reduces health problems that could add extra nerve damage. nhs.uk+2Lone Star Neurology+2
7. Is exercise dangerous for my nerves?
Over-intense or high-impact exercise may cause injuries, but well-planned, low-impact exercise designed by your physiotherapist is usually safe and helpful. It strengthens muscles that are still working, improves balance, and supports heart health. The key is regular, gentle, and guided activity. PMC+2Mayo Clinic+2
8. Will I need a wheelchair?
Some people with CMT1E may eventually use a wheelchair for longer distances, especially as they age, but many still walk short distances with braces or aids. Early therapy, good braces, and timely surgery can delay or reduce the need for full-time wheelchair use. PMC+2PMC+2
9. Can CMT1E affect my breathing or heart?
CMT mainly affects peripheral nerves, but severe deformity of the spine or chest, or co-existing sleep problems, can stress breathing. Regular check-ups assess for breathing or sleep issues. Direct heart nerve involvement is less common but general heart health should still be protected with good lifestyle choices. PMC+2PMC+2
10. Is pregnancy safe if I have CMT1E?
Many people with CMT have successful pregnancies. Symptoms like weakness or balance issues may temporarily worsen due to weight gain and hormonal changes. Obstetric and neurology teams should plan safe delivery and fall-prevention strategies. Genetic counselling helps you understand the chance of passing CMT1E to a child. CMT Research Foundation+1
11. Can children with CMT1E play sports?
Children with CMT1E can usually join modified physical activities. Swimming, cycling, and supervised strength exercises are often good choices. High-impact contact sports or activities with high fall risk should be avoided or adapted. A paediatric neurologist and physiotherapist can guide safe options. Mayo Clinic+1
12. How often should I see my neurologist?
Most people benefit from at least yearly neurology visits, plus more frequent rehabilitation or orthopaedic visits when symptoms change or new problems arise. After surgery or major treatment changes, follow-up is usually more frequent until things are stable again. PMC+2PMC+2
13. Are there clinical trials for CMT1E?
Several clinical trials study new drugs, gene therapies, or rehabilitation methods for different CMT subtypes. Some focus on PMP22-related disease. Eligibility depends on your genetic test results, age, and health. You can ask your neurologist or check major clinical trial registries to see current options. NeurologyLive+5PMC+5PMC+5
14. Does CMT1E affect life expectancy?
Most people with CMT, including CMT1E, have a near-normal life expectancy, especially with good care. The main impact is on movement, independence, and daily comfort, not usually on survival. Good management of falls, infections, and general health makes long, active life more likely. PMC+2PMC+2
15. What is the most important thing I can do right now?
The most powerful steps are: confirm your exact diagnosis and gene result, start or continue regular physiotherapy and orthotic use, manage pain with safe medicines if needed, and protect feet and overall health. Building a trusted team—neurologist, therapists, orthotist, and counsellor—gives you the best long-term outcome. Charcot-Marie-Tooth Association+4CMT Research Foundation+4PMC+4
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.
